Shares of NewAmsterdam Pharma rose in premarket trading Monday after finding positive benefits for treating Alzheimer's Disease in its cholesterol drug study. Shares traded 9.2% higher ahead of the ...

Pre-specified analyses show that obicetrapib treatment leads to statistically significant and clinically meaningful reductions in the primary outcome measure of Alzheimer’s disease biomarker in both ...

While these numbers may sound worrying, the study also gives us hope. It shows that Alzheimer’s risk isn’t only written in ...

Examining blood lipid levels may help physicians predict a patient’s risk of developing Alzheimer’s disease, according to a study published May 30 in Neurology.  Here are five notes on the study: Read ...

People who are at higher risk for heart disease also seem more likely to develop dementia. And research led by The University ...

People at higher risk for heart disease may also be more likely to develop dementia, according to new research led by The ...

New dementia diagnoses have significantly decreased since 2015, a study published in BMJ found.But more people are living ...

A person aged 75 to 80 is less likely to have dementia today compared to someone of the same age several decades ago, a ...

Dementia cases were most strongly associated with stroke, with a 2.2-times higher risk, followed by heart failure (2.1 times ...

A person aged 75 to 80 is less likely to have dementia today compared to someone of the same age several decades ago, a ...

There is "such positivity" in Alzheimer’s research at the moment, says top immunologist Luke O’Neill. A drug that slows down ...

In Hawaii, Alzheimer’s disease affects about 11% of people 65 and older, or about 31,000 kupuna. Researchers say that number ...